Windhover.com | Medtech Insight | The RPM Report | Inteleos | FDC Reports
Subscriber Username:   Password: Forgot Password?
Search Articles:
Advanced Search
 

Home
About Us
Publications
Databases
Conferences
Article Search
The IN VIVO Blog
Company Profiles
Contact Us
Help


Receive Windhover's unique market insight fast with our free alert service 'Windhover's Update', including the latest abstracts and summaries from:

• IN VIVO
• Start-Up
• The RPM Report
• Medtech Insight


Sign up now




Providing unparalleled analysis and insight of the deals and products
shaping the Health Care industry.


Subscriber Login

Strategic Transactions delivers the most comprehensive deals data in the industry, including alliances, financings and M&As across biopharmaceuticals, devices, diagnostics and tech transfers. Better yet, it’s the only database with available, hyperlinked analysis from Windhover’s award-winning editorial staff.

You'll receive:

  • More than 24,000 deals from 1991 to the present
  • Summaries of company, product and financial information, plus SEC & contract filings
  • Simple and sophisticated search that’s fully exportable
  • Extensive cross-linking of deals, companies and commentary
  • Regular e-newsletter includes new and updated deals
  • Thoroughly fact-checked by a dedicated team of analysts

Benchmark competitors, evaluate comparable deals, gather authoritative data for negotiations, and profile potential partners with Strategic Transactions. Learn more!

Inteleos offers the in-depth drug information you need to fully understand the value of a deal for a particular drug and be confident in your dealmaking decisions.
Upgrade your Strategic Transactions subscription to include the latest product pipeline data from Inteleos. Learn more.

Subscriber Login

Inteleos features comprehensive data on more than 10,000 drugs and biologics, complete with in-depth regulatory coverage, detailed development timelines and competitor profiles. Inteleos is the premier business intelligence tool and offers intuitive indexing and search capabilities with flexible export options to fulfill your drug development research needs.

You'll receive:

  • Track biologic and drug development from preclinical through approval and post-marketing studies
  • Find information about new partners and stay up to date on competitor's activities
  • In depth regulatory submission and approval filings with industry, conference and regulatory news from leading Elsevier sources
  • Detailed clinical trial info
  • Graphically dynamic analysis tools to view content from different perspectives
  • Personalized alerts on content updates relevant to your portfolio

Inteleos is the most intuitive, flexible tool for drug pipeline, research, tracking and analysis. Learn more!


Subscriber Login

Transaction Tracker is Windhover’s snapshot of current pharmaceutical dealmaking activity, featuring the most recent two months of data plus analysis of the latest trends. It’s the most popular features of Strategic Transactions at an affordable price!

You'll receive:

  • Dealmaking activity: A complete picture of the most recent two months of transactions
  • Dedicated homepage: A homepage exclusively for Transaction Tracker subscribers that’s user-friendly and convenient
  • Deal updates: Continual updates of earlier deals
  • FREE weekly email: An available, FREE weekly email newsletter to alert you to the hottest new activity
  • Analysis & commentary: Selected trend analysis from Windhover's dedicated editorial team
  • Profiles: In-depth profiles of all deal-active companies

Transaction Tracker is designed to help you stay on top of the fast-moving dealmaking landscape and identify risks and opportunities for your business across the industry. Learn more!


To request further information on the FDC-Windhover suite of database products, please contact James DeFalco at (203) 838-4401 ext: 104 or via email at: jdefalco@windhover.com

The IN VIVO Blog

In3 West
March 2-4, 2009 · Las Vegas, NV

Pharmaceutical Strategic Outlook
April 13-15, 2009 · New York, NY

BIO-Windhover 2009
April 13-15, 2009 · New York, NY

Interested in presenting at a Windhover conference?
Submit your idea here


Can Big Pharma Save Biotech Investors?
All the biotech stock indices are down; record numbers of companies are selling at lower-than-cash valuations. Investors . . . [MORE . . .] (IN VIVO)

Will Simpler Devices Tap the Largest Diabetes Market?
The clinical community and the medical device industry are finally turning their attention to the majority of patients with . . .[MORE. . .] (Start-Up)

New Technologies Help Hospitals Tackle Patient Safety Push
CMS continues to tighten its rules on so-called "never events" - conditions acquired during hospitalization - in an ongoing . . .[MORE. . .] (Medtech Insight)

Treat and Trade: The New Priority Review Voucher Market
Starting in September, pharmaceutical companies will have the opportunity to buy the right to a faster FDA review on the . . . [MORE. . .] (The RPM Report)

Read more from this month's: IN VIVO, Start-Up, The RPM Report, and Medtech Insight.

Publications - Databases - Conferences - About Us - Contact Us - Help - The IN VIVO Blog - Company Profiles - Subscriber Login

Copyright © 2008, Windhover Information, Inc. All rights reserved. An Elsevier company.